Fecal Calprotectin Levels, C-Reactive Protein Levels, and Partial Mayo Score as Early Predictors of Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Treated With Tofacitinib in a Phase 2 Study

被引：1
|
作者：
Dubinsky, Marla C. [1 ]
Hudesman, David P. [2 ]
Kulisek, Nicole [3 ]
Salese, Leonardo [3 ]
Paulissen, Jerome [4 ]
Su, Chinyu [3 ]
Magro, Fernando [5 ,6 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] New York Univ Langone Hlth, New York, NY USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Syneos Hlth, Morrisville, NC USA
[5] Univ Porto, Porto, Portugal
[6] Ctr Hosp Sao Joao, Porto, Portugal
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000592828.44710.08
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
823
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [21] Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
    Schoepfer, Alain M.
    Beglinger, Christoph
    Straumann, Alex
    Safroneeva, Ekaterina
    Romero, Yvonne
    Armstrong, David
    Schmidt, Carsten
    Trummler, Michael
    Pittet, Valerie
    Vavricka, Stephan R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 332 - 341
  • [22] Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'
    Pethoe-Schramm, Attila
    Devenport, Jenny
    Reiss, William
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [23] Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis
    Natsuki Ishida
    Satoshi Tamura
    Takahiro Miyazu
    Shinya Tani
    Mihoko Yamade
    Moriya Iwaizumi
    Yasushi Hamaya
    Satoshi Osawa
    Takahisa Furuta
    Ken Sugimoto
    [J]. Scientific Reports, 11
  • [24] Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis
    Ishida, Natsuki
    Tamura, Satoshi
    Miyazu, Takahiro
    Tani, Shinya
    Yamade, Mihoko
    Iwaizumi, Moriya
    Hamaya, Yasushi
    Osawa, Satoshi
    Furuta, Takahisa
    Sugimoto, Ken
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Serum levels of β2 microglobulin and ultrasensitive c-reactive protein as markers of histological activity in ulcerative colitis.
    Yamamoto-Furusho, Jesus K.
    Camacho-Escobedo, Jesus
    Tellez-Avila, Felix
    Barreto, Rafael
    [J]. GACETA MEDICA DE MEXICO, 2010, 146 (01): : 31 - 35
  • [26] Fecal Calprotectin, Serum Ferritin, and C-Reactive Protein Levels in Individuals with Inflammatory Bowel Disease Concomitant with Type 2 Diabetes: A Retrospective Study
    Sargautiene, Vanda
    Gavars, Didzis
    Ligere, Renate
    [J]. CLINICAL DIABETOLOGY, 2024, 13 (02): : 106 - 115
  • [27] FAECAL CALPROTECTIN TO PREDICT THE RISK OF RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION AND ENDOSCOPIC MAYO SCORE 0 OR 1: RESULTS OF THE CALPRODICT-UC STUDY
    Buisson, Anthony
    Carpentier, Constantin
    Minet-Quinard, Regine
    Pereira, Bruno
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S884 - S884
  • [28] IMA-638 in Active Ulcerative Colitis from a Phase IIa Multicenter Study: Correlation between Fecal Calprotectin Levels and Clinical Activity
    Khurana, Sunil
    Panes, Julian
    Cataldi, Fabio
    Hanlon, Beth
    De Micco, Philip
    Comer, Gail
    Toth, Gabor
    Petrov, Plamen
    Yuan, Guojun
    Hua, Fei
    Hinz, Michelle
    Page, Karen
    McDonnell, Tara
    Reinisch, Walter
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S529 - S530
  • [29] Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study
    Drabik, Attyla
    Sturm, Andreas
    Bloemacher, Margit
    Helwig, Ulf
    [J]. JMIR RESEARCH PROTOCOLS, 2016, 5 (02):
  • [30] Rapid fecal calprotectin testing predicts mucosal healing better than C-reactive protein and serum tumor necrosis factor alpha in patients with ulcerative colitis
    Voiosu, T.
    Bengus, Andreea
    Balanescu, P.
    Dinu, Roxana
    Voiosu, A.
    Baicus, C.
    Mateescu, B.
    [J]. ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2015, 53 (03) : 253 - 260
12345